Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
Not Confirmed
Not Confirmed
30 September-02 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Industry Trade Show
Not Confirmed
30 September-02 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
24 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/24/2952593/0/en/Lyell-Immunopharma-Announces-Participation-in-Goldman-Sachs-Cell-Therapy-Day.html
28 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/28/2937351/0/en/Lyell-Immunopharma-Announces-Participation-in-September-Investor-Conferences.html
07 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/07/2926322/0/en/Lyell-Immunopharma-Reports-Business-Highlights-and-Financial-Results-for-the-Second-Quarter-2024.html
26 Jun 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/car-t-death-drives-lyell-take-2-track-approach-dose-escalation
26 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/26/2904373/0/en/Lyell-Immunopharma-Reports-Dose-dependent-Clinical-Activity-from-Phase-1-Trial-of-LYL797-a-ROR1-targeted-CAR-T-Cell-Product-Candidate-Enhanced-with-its-Proprietary-Anti-exhaustion-.html
03 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/03/2892587/0/en/Lyell-Immunopharma-to-Participate-in-the-Goldman-Sachs-Global-Healthcare-Conference.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?